Thinking about vaccine results (AstraZeneca redux)

The 70% effectiveness rate that AstraZeneca and the University of Oxford announced last Monday is promising at first glance, but details about this vaccine’s clinical trials have puzzled epidemiologists. Here’s what to consider as we await more details on AstraZeneca and Oxford’s findings, drawing on reports from STAT News, Nature, and the New York Times.

Read More